BRANDED GENERICS MARKET ANALYSIS
Global Branded Generics Market – Driver
Off-invoice discounts to fuel growth of the global branded generics market
Due to greater reductions provided by competitors, the demand for branded generic medications is anticipated to be significant in developed markets such as the U.S. In the U.S., off-invoice discounts average about 30% compared to 17% in the EU.
Global Branded Generics Market: Restraint
Price pressure from payers to hinder market growth
Governments and insurers in emerging economies encourage consumers to switch from branded generics to low cost generics in order to contain healthcare costs. Moreover, several emerging countries taking lower benchmark prices from European/International core countries cluster to drive down the prices. For instance, in countries such as Turkey, South Africa, payers adopted international benchmarking of prices and purchasing large volumes of inexpensive generic medicines to curtail the healthcare expenditure.
Global Branded Generics Market - Key Players
Major players operating in the global branded generics market include, Mylan N.V, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Aspen Pharmacare Holding Ltd., Abbott Laboratories, and Valeant Pharmaceuticals International, Inc.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
